title: Induction of CD94/NKG2A expression on T cells in mixed lymphocyte culture by CD14+ cells from granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells.
abstract: We report the increased expression of inhibitory natural killer (NK) cell receptor, CD94/NKG2A, for human leucocyte antigen (HLA) class I on CD8+ T cells in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cells (G-PBMC) after mixed lymphocyte culture (MLC). The addition of purified CD14+ cells to CD14-depleted G-PBMC-induced CD94/NKG2A expression in a dose-dependent fashion; however, this enhancing effect was inhibited by the membrane between responder cells and CD14+ cells. Therefore, CD14+ cells in G-PBMC induce CD94/NKG2A expression on CD8+ T cells, which in turn appear to downregulate alloresponses after allogeneic peripheral blood stem cell transplantation.
authors.affiliation: Department of Haematology and Oncology, Graduate School of Medicine, N15 W7, Kita-ku, Sapporo 060-8638, Japan. jutanaka@med.hokudai.ac.jp
authors.forename: Junji
authors.initials: J
authors.lastname: Tanaka
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Tutumi
authors.forename: Zhang
authors.initials: Z
authors.lastname: Li
authors.forename: Naoko
authors.initials: N
authors.lastname: Katho
authors.forename: Junichi
authors.initials: J
authors.lastname: Sugita
authors.forename: Akio
authors.initials: A
authors.lastname: Mori
authors.forename: Nobuyasu
authors.initials: N
authors.lastname: Toyoshima
authors.forename: Shuichi
authors.initials: S
authors.lastname: Ota
authors.forename: Masanobu
authors.initials: M
authors.lastname: Kobayashi
authors.forename: Masaharu
authors.initials: M
authors.lastname: Kasai
authors.forename: Masahiro
authors.initials: M
authors.lastname: Asaka
authors.forename: Masahiro
authors.initials: M
authors.lastname: Imamura
mesh_terms: D015703:Antigens, CD / Q000378:metabolism*; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology*; D002455:Cell Division / Q000276:immunology; D016179:Granulocyte Colony-Stimulating Factor / Q000494:pharmacology; D019650:Hematopoietic Stem Cell Mobilization; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology; D037181:Lectins, C-Type; D000078224:Lenograstim; D007963:Leukocytes, Mononuclear / Q000276:immunology*; D018950:Lipopolysaccharide Receptors / Q000032:analysis*; D008213:Lymphocyte Activation; D007959:Lymphocyte Culture Test, Mixed; D008562:Membrane Glycoproteins / Q000378:metabolism*; D055654:NK Cell Lectin-Like Receptor Subfamily C; D051920:NK Cell Lectin-Like Receptor Subfamily D; D011971:Receptors, Immunologic / Q000378:metabolism*; D011975:Receptors, Mitogen / Q000378:metabolism; D055607:Receptors, Natural Killer Cell; D011994:Recombinant Proteins / Q000494:pharmacology
chemical_list: D015703:Antigens, CD; C527054:KLRC1 protein, human; C497869:KLRD1 protein, human; D037181:Lectins, C-Type; D018950:Lipopolysaccharide Receptors; D008562:Membrane Glycoproteins; D055654:NK Cell Lectin-Like Receptor Subfamily C; D051920:NK Cell Lectin-Like Receptor Subfamily D; D011971:Receptors, Immunologic; D011975:Receptors, Mitogen; D055607:Receptors, Natural Killer Cell; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D000078224:Lenograstim